222 related articles for article (PubMed ID: 22943522)
1. Atypical subtrochanteric fractures, bisphosphonates, blinded radiological review.
Warren C; Gilchrist N; Coates M; Frampton C; Helmore J; McKie J; Hooper G
ANZ J Surg; 2012 Dec; 82(12):908-12. PubMed ID: 22943522
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-related complete atypical subtrochanteric femoral fractures: diagnostic utility of radiography.
Rosenberg ZS; La Rocca Vieira R; Chan SS; Babb J; Akyol Y; Rybak LD; Moore S; Bencardino JT; Peck V; Tejwani NC; Egol KA
AJR Am J Roentgenol; 2011 Oct; 197(4):954-60. PubMed ID: 21940585
[TBL] [Abstract][Full Text] [Related]
3. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
[TBL] [Abstract][Full Text] [Related]
4. Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates.
Puhaindran ME; Farooki A; Steensma MR; Hameed M; Healey JH; Boland PJ
J Bone Joint Surg Am; 2011 Jul; 93(13):1235-42. PubMed ID: 21776577
[TBL] [Abstract][Full Text] [Related]
5. Salvage of failed osteosynthesis for an atypical subtrochanteric femoral fracture associated with long-term bisphosphonate treatment using a 95° angled blade plate.
Kim SM; Rhyu KH; Lim SJ
Bone Joint J; 2018 Nov; 100-B(11):1511-1517. PubMed ID: 30418051
[TBL] [Abstract][Full Text] [Related]
6. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.
Shane E; Burr D; Ebeling PR; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster D; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Koval K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Sen HT; van der Meulen MC; Weinstein RS; Whyte M;
J Bone Miner Res; 2010 Nov; 25(11):2267-94. PubMed ID: 20842676
[TBL] [Abstract][Full Text] [Related]
7. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Rizzoli R; Akesson K; Bouxsein M; Kanis JA; Napoli N; Papapoulos S; Reginster JY; Cooper C
Osteoporos Int; 2011 Feb; 22(2):373-90. PubMed ID: 21085935
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ;
N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571
[TBL] [Abstract][Full Text] [Related]
9. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.
Thompson RN; Phillips JR; McCauley SH; Elliott JR; Moran CG
J Bone Joint Surg Br; 2012 Mar; 94(3):385-90. PubMed ID: 22371548
[TBL] [Abstract][Full Text] [Related]
10. Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features.
Giusti A; Hamdy NA; Dekkers OM; Ramautar SR; Dijkstra S; Papapoulos SE
Bone; 2011 May; 48(5):966-71. PubMed ID: 21195812
[TBL] [Abstract][Full Text] [Related]
11. Rare non-traumatic periprosthetic femoral fracture with features of an atypical femoral fracture: a case report.
Niikura T; Lee SY; Sakai Y; Kuroda R; Kurosaka M
J Med Case Rep; 2015 May; 9():103. PubMed ID: 25943378
[TBL] [Abstract][Full Text] [Related]
12. Burden of bisphosphonate-associated femoral fractures.
Shkolnikova J; Flynn J; Choong P
ANZ J Surg; 2013 Mar; 83(3):175-81. PubMed ID: 23216704
[TBL] [Abstract][Full Text] [Related]
13. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
Park KT; Lee KB
Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
[TBL] [Abstract][Full Text] [Related]
14. Identifying atypical femoral fractures--a retrospective review.
Juby AG; Crowther S; Cree M
Calcif Tissue Int; 2014 Nov; 95(5):405-12. PubMed ID: 25209972
[TBL] [Abstract][Full Text] [Related]
15. Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene.
Vestergaard P; Schwartz F; Rejnmark L; Mosekilde L
Osteoporos Int; 2011 Mar; 22(3):993-1001. PubMed ID: 21165600
[TBL] [Abstract][Full Text] [Related]
16. Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.
Meier RP; Perneger TV; Stern R; Rizzoli R; Peter RE
Arch Intern Med; 2012 Jun; 172(12):930-6. PubMed ID: 22732749
[TBL] [Abstract][Full Text] [Related]
17. Atypical subtrochanteric fractures after long-term bisphosphonate therapy.
Czerwiński E
Endokrynol Pol; 2011; 62(1):84-7. PubMed ID: 21365585
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate-related subtrochanteric femoral fractures.
Gunawardena I; Baxter M; Rasekh Y
Am J Geriatr Pharmacother; 2011 Jun; 9(3):194-8. PubMed ID: 21470918
[TBL] [Abstract][Full Text] [Related]
19. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
Chang ST; Tenforde AS; Grimsrud CD; O'Ryan FS; Gonzalez JR; Baer DM; Chandra M; Lo JC
Bone; 2012 Sep; 51(3):524-7. PubMed ID: 22634175
[TBL] [Abstract][Full Text] [Related]
20. Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.
Lim SJ; Yeo I; Yoon PW; Yoo JJ; Rhyu KH; Han SB; Lee WS; Song JH; Min BW; Park YS
Osteoporos Int; 2018 Nov; 29(11):2427-2435. PubMed ID: 30039251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]